Logo image of HSAI

HESAI GROUP (HSAI) Stock Fundamental Analysis

NASDAQ:HSAI - Nasdaq - US4280501085 - ADR - Currency: USD

21.93  +1.2 (+5.79%)

After market: 21.8 -0.13 (-0.59%)

Fundamental Rating

4

HSAI gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 81 industry peers in the Automobile Components industry. HSAI scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. HSAI shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year HSAI was profitable.
HSAI had negative earnings in each of the past 5 years.
In multiple years HSAI reported negative operating cash flow during the last 5 years.
HSAI Yearly Net Income VS EBIT VS OCF VS FCFHSAI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -500M -1B -1.5B -2B

1.2 Ratios

HSAI has a worse Return On Assets (-0.23%) than 72.84% of its industry peers.
HSAI's Return On Equity of -0.31% is on the low side compared to the rest of the industry. HSAI is outperformed by 71.60% of its industry peers.
Industry RankSector Rank
ROA -0.23%
ROE -0.31%
ROIC N/A
ROA(3y)-9.86%
ROA(5y)-19.98%
ROE(3y)-13.74%
ROE(5y)-26.23%
ROIC(3y)N/A
ROIC(5y)N/A
HSAI Yearly ROA, ROE, ROICHSAI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

Looking at the Gross Margin, with a value of 42.99%, HSAI belongs to the top of the industry, outperforming 97.53% of the companies in the same industry.
HSAI's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for HSAI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 42.99%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.03%
GM growth 5Y-9.55%
HSAI Yearly Profit, Operating, Gross MarginsHSAI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

More info and screens

6

2. Health

2.1 Basic Checks

HSAI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, HSAI has less shares outstanding
HSAI has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, HSAI has a worse debt to assets ratio.
HSAI Yearly Shares OutstandingHSAI Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
HSAI Yearly Total Debt VS Total AssetsHSAI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

HSAI has an Altman-Z score of 8.27. This indicates that HSAI is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 8.27, HSAI belongs to the top of the industry, outperforming 91.36% of the companies in the same industry.
HSAI has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
With an excellent Debt to Equity ratio value of 0.08, HSAI belongs to the best of the industry, outperforming 88.89% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Altman-Z 8.27
ROIC/WACCN/A
WACC8.01%
HSAI Yearly LT Debt VS Equity VS FCFHSAI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

HSAI has a Current Ratio of 4.06. This indicates that HSAI is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of HSAI (4.06) is better than 91.36% of its industry peers.
HSAI has a Quick Ratio of 3.62. This indicates that HSAI is financially healthy and has no problem in meeting its short term obligations.
HSAI has a Quick ratio of 3.62. This is amongst the best in the industry. HSAI outperforms 93.83% of its industry peers.
Industry RankSector Rank
Current Ratio 4.06
Quick Ratio 3.62
HSAI Yearly Current Assets VS Current LiabilitesHSAI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

More info and screens

8

3. Growth

3.1 Past

HSAI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 126.02%, which is quite impressive.
The Revenue has grown by 24.20% in the past year. This is a very strong growth!
HSAI shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 42.94% yearly.
EPS 1Y (TTM)126.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%111.11%
Revenue 1Y (TTM)24.2%
Revenue growth 3Y42.3%
Revenue growth 5Y42.94%
Sales Q2Q%46.27%

3.2 Future

The Earnings Per Share is expected to grow by 215.76% on average over the next years. This is a very strong growth
HSAI is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 40.14% yearly.
EPS Next Y6800.94%
EPS Next 2Y1131.68%
EPS Next 3Y494.97%
EPS Next 5Y215.76%
Revenue Next Year57.04%
Revenue Next 2Y50.74%
Revenue Next 3Y42.62%
Revenue Next 5Y40.14%

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
HSAI Yearly Revenue VS EstimatesHSAI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 5B 10B 15B 20B 25B
HSAI Yearly EPS VS EstimatesHSAI Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 0 5 -5 10

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 243.67, which means the current valuation is very expensive for HSAI.
Based on the Price/Earnings ratio, HSAI is valued expensively inside the industry as 80.25% of the companies are valued cheaper.
HSAI's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.45.
A Price/Forward Earnings ratio of 25.88 indicates a quite expensive valuation of HSAI.
Compared to the rest of the industry, the Price/Forward Earnings ratio of HSAI indicates a slightly more expensive valuation: HSAI is more expensive than 74.07% of the companies listed in the same industry.
HSAI's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 21.90.
Industry RankSector Rank
PE 243.67
Fwd PE 25.88
HSAI Price Earnings VS Forward Price EarningsHSAI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, HSAI is valued expensively inside the industry as 85.19% of the companies are valued cheaper.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 648.05
HSAI Per share dataHSAI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
HSAI's earnings are expected to grow with 494.97% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.04
PEG (5Y)N/A
EPS Next 2Y1131.68%
EPS Next 3Y494.97%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for HSAI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HESAI GROUP

NASDAQ:HSAI (7/3/2025, 7:34:22 PM)

After market: 21.8 -0.13 (-0.59%)

21.93

+1.2 (+5.79%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)05-26 2025-05-26/amc
Earnings (Next)08-18 2025-08-18
Inst Owners54.92%
Inst Owner Change24.73%
Ins Owners0.47%
Ins Owner ChangeN/A
Market Cap2.91B
Analysts85.71
Price Target25.69 (17.15%)
Short Float %5.82%
Short Ratio1.23
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)66.12%
Min EPS beat(2)-13.01%
Max EPS beat(2)145.25%
EPS beat(4)2
Avg EPS beat(4)10.14%
Min EPS beat(4)-108.33%
Max EPS beat(4)145.25%
EPS beat(8)6
Avg EPS beat(8)21.71%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.85%
Min Revenue beat(2)-3.22%
Max Revenue beat(2)-2.48%
Revenue beat(4)1
Avg Revenue beat(4)-0.64%
Min Revenue beat(4)-4.88%
Max Revenue beat(4)8.02%
Revenue beat(8)4
Avg Revenue beat(8)2.26%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)7.91%
PT rev (3m)7.49%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)4.48%
EPS NY rev (3m)11.47%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-2.66%
Revenue NY rev (3m)-2.21%
Valuation
Industry RankSector Rank
PE 243.67
Fwd PE 25.88
P/S 9.27
P/FCF N/A
P/OCF N/A
P/B 4.86
P/tB 4.96
EV/EBITDA 648.05
EPS(TTM)0.09
EY0.41%
EPS(NY)0.85
Fwd EY3.86%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS2.36
BVpS4.51
TBVpS4.42
PEG (NY)0.04
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.23%
ROE -0.31%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 42.99%
FCFM N/A
ROA(3y)-9.86%
ROA(5y)-19.98%
ROE(3y)-13.74%
ROE(5y)-26.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.03%
GM growth 5Y-9.55%
F-ScoreN/A
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Debt/EBITDA 10.73
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.06
Quick Ratio 3.62
Altman-Z 8.27
F-ScoreN/A
WACC8.01%
ROIC/WACCN/A
Cap/Depr(3y)378.06%
Cap/Depr(5y)506.05%
Cap/Sales(3y)18.38%
Cap/Sales(5y)22.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)126.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%111.11%
EPS Next Y6800.94%
EPS Next 2Y1131.68%
EPS Next 3Y494.97%
EPS Next 5Y215.76%
Revenue 1Y (TTM)24.2%
Revenue growth 3Y42.3%
Revenue growth 5Y42.94%
Sales Q2Q%46.27%
Revenue Next Year57.04%
Revenue Next 2Y50.74%
Revenue Next 3Y42.62%
Revenue Next 5Y40.14%
EBIT growth 1Y82.99%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year262.82%
EBIT Next 3Y89.56%
EBIT Next 5Y71.4%
FCF growth 1Y42.08%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y11.77%
OCF growth 3YN/A
OCF growth 5Y6.75%